Methylene Chloride

Methylene Chloride

SCHEMBL4572767

ClCCl.O=C=NC(=O)c1ccc(F)cc1Cl

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.43
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ PYGL P06737 2/20 0.38
▸ CTSL P07711 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ P2RX7 Q99572 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ CES2 O00748 1/20 0.37
▸ CES1 P23141 1/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ ALOX15 P16050 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2916902 0.95 HPGD (0.46) HPGDNPC1RAB9APYGLALDH1A1
SCHEMBL10803361 0.82 CES2 (0.40) HPGDALDH1A1CES2CES1MAPK1
SCHEMBL10643675 0.81 HPGD (0.45) HPGDNPC1RAB9APYGLALDH1A1
SCHEMBL5314369 0.78 CES2 (0.57) NPC1RAB9AALDH1A1CES2CES1
SCHEMBL4643747 0.78 TSHR (0.55) HPGDNPC1RAB9AALDH1A1LMNA
SCHEMBL10747308 0.76 CES2 (0.40) HPGDNPC1RAB9AALDH1A1P2RX7
SCHEMBL1121904 0.75 POLB (0.45) HPGDNPC1RAB9ALMNAGAA
SCHEMBL10585954 0.75 CES2 (0.57) ALDH1A1CES2CES1
SCHEMBL11010263 0.72 CES2 (0.40) NPC1RAB9AALDH1A1LMNAPKM
SCHEMBL8348114 0.72 TRPA1 (0.42) HPGDNPC1RAB9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8247452-B2 Urea- and urethane-substituted acylureas, process for their preparation and their use SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2012-08-21 — — US disclosed
US-20080033042-A1 UREA-AND URETHANE-SUBSTITUTED ACYLUREAS, PROCESS FOR THEIR PREPARATION AND THEIR USE SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-02-07 — — US disclosed
US-7262220-B2 Urea- and urethane-substituted acylureas, process for their preparation and their use SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-08-28 — — US disclosed
US-20040087659-A1 Urea- and urethane-substituted acylureas, process for their preparation and their use SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2004-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087659-A1 Urea- and urethane-substituted acylureas, process for their preparation and their use UGP2, UGDH, UGT1A1 HPGD 996/4885NPC1 1871/4885RAB9A 4087/4885
US-20080033042-A1 UREA-AND URETHANE-SUBSTITUTED ACYLUREAS, PROCESS FOR THEIR PREPARATION AND THEIR USE UGP2, UGDH, UMPS HPGD 918/4885NPC1 2266/4885RAB9A 4077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback